Global Prophylactic Gamma Globulin Market Growth 2025-2031
Description
The global Prophylactic Gamma Globulin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The gamma globulin fraction of pooled normal human sera has a wide range of usefulness in the prophylaxis of many infectious diseases. Hyperimmune human globulin preparations are effective against certain other illnesses in which globulins pooled from normal sera contain insufficient antibody.
United States market for Prophylactic Gamma Globulin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Prophylactic Gamma Globulin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Prophylactic Gamma Globulin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Prophylactic Gamma Globulin players cover Baxter, Grifols, Octapharma, Biotest, Kedrion Biopharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Prophylactic Gamma Globulin Industry Forecast” looks at past sales and reviews total world Prophylactic Gamma Globulin sales in 2024, providing a comprehensive analysis by region and market sector of projected Prophylactic Gamma Globulin sales for 2025 through 2031. With Prophylactic Gamma Globulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prophylactic Gamma Globulin industry.
This Insight Report provides a comprehensive analysis of the global Prophylactic Gamma Globulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prophylactic Gamma Globulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prophylactic Gamma Globulin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prophylactic Gamma Globulin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prophylactic Gamma Globulin.
This report presents a comprehensive overview, market shares, and growth opportunities of Prophylactic Gamma Globulin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
IVIg Liquid
IVIg Powder
Segmentation by Application:
Immunodeficiency
Autoimmune Disease
Acute Infection
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Baxter
Grifols
Octapharma
Biotest
Kedrion Biopharma
Takeda
ADMA Biologics
BPL
LFB Group
Hualan Biological
Beijing Tiantan Biological
Beijing Bohui Innovation Biotechnology
Pacific Shuanglin Bio-pharmacy
Shenzhen Weiguang Biological
CBPO
CNBG
Shanghai RAAS
Sichuan Yuanda Shuyang
Key Questions Addressed in this Report
What is the 10-year outlook for the global Prophylactic Gamma Globulin market?
What factors are driving Prophylactic Gamma Globulin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Prophylactic Gamma Globulin market opportunities vary by end market size?
How does Prophylactic Gamma Globulin break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The gamma globulin fraction of pooled normal human sera has a wide range of usefulness in the prophylaxis of many infectious diseases. Hyperimmune human globulin preparations are effective against certain other illnesses in which globulins pooled from normal sera contain insufficient antibody.
United States market for Prophylactic Gamma Globulin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Prophylactic Gamma Globulin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Prophylactic Gamma Globulin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Prophylactic Gamma Globulin players cover Baxter, Grifols, Octapharma, Biotest, Kedrion Biopharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Prophylactic Gamma Globulin Industry Forecast” looks at past sales and reviews total world Prophylactic Gamma Globulin sales in 2024, providing a comprehensive analysis by region and market sector of projected Prophylactic Gamma Globulin sales for 2025 through 2031. With Prophylactic Gamma Globulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prophylactic Gamma Globulin industry.
This Insight Report provides a comprehensive analysis of the global Prophylactic Gamma Globulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prophylactic Gamma Globulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prophylactic Gamma Globulin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prophylactic Gamma Globulin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prophylactic Gamma Globulin.
This report presents a comprehensive overview, market shares, and growth opportunities of Prophylactic Gamma Globulin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
IVIg Liquid
IVIg Powder
Segmentation by Application:
Immunodeficiency
Autoimmune Disease
Acute Infection
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Baxter
Grifols
Octapharma
Biotest
Kedrion Biopharma
Takeda
ADMA Biologics
BPL
LFB Group
Hualan Biological
Beijing Tiantan Biological
Beijing Bohui Innovation Biotechnology
Pacific Shuanglin Bio-pharmacy
Shenzhen Weiguang Biological
CBPO
CNBG
Shanghai RAAS
Sichuan Yuanda Shuyang
Key Questions Addressed in this Report
What is the 10-year outlook for the global Prophylactic Gamma Globulin market?
What factors are driving Prophylactic Gamma Globulin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Prophylactic Gamma Globulin market opportunities vary by end market size?
How does Prophylactic Gamma Globulin break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
131 Pages
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Prophylactic Gamma Globulin by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Prophylactic Gamma Globulin by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
